Eagle Asset Management’s Axonics, Inc. Common Stock AXNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-151,268
Closed -$9.41M – 626
2023
Q4
$9.41M Sell
151,268
-5,920
-4% -$331K 0.05% 278
2023
Q3
$8.82M Sell
157,188
-217,157
-58% -$12.2M 0.05% 279
2023
Q2
$18.9M Sell
374,345
-11,354
-3% -$604K 0.11% 193
2023
Q1
$21M Buy
385,699
+22,018
+6% +$1.29M 0.12% 159
2022
Q4
$21.7M Buy
363,681
+8,958
+3% +$594K 0.13% 163
2022
Q3
$25M Buy
354,723
+249,443
+237% +$17.2M 0.16% 152
2022
Q2
$5.97M Sell
105,280
-155
-0.1% -$8.5K 0.04% 324
2022
Q1
$6.6M Sell
105,435
-4,748
-4% -$256K 0.03% 344
2021
Q4
$6.19M Sell
110,183
-13,576
-11% -$830K 0.03% 376
2021
Q3
$8.05M Sell
123,759
-16,120
-12% -$1.1M 0.04% 350
2021
Q2
$8.87M Sell
139,879
-5,443
-4% -$321K 0.04% 347
2021
Q1
$8.52M Buy
145,322
+12,664
+10% +$689K 0.04% 354
2020
Q4
$6.62M Buy
132,658
+77,735
+142% +$3.65M 0.04% 350
2020
Q3
$2.71M Buy
+54,923
New +$2.29M 0.01% 418

Other funds holding AXNX

Eagle Asset Management's AXNX Position: Q1 2024 in Review

Eagle Asset Management sold out of Axonics, Inc. Common Stock (AXNX) in Q1 2024, closing a stake of 151,268 shares — an estimated $9.41M sold.

Eagle Asset Management first reported a position in AXNX in Q3 2020 and held it in 14 quarters. The position peaked at $25M in Q3 2022. 235 funds tracked by Wall St. Rank hold AXNX as of Q1 2024.

  • Eagle Asset Management reported no remaining Axonics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Eagle Asset Management sold 151,268 Axonics, Inc. Common Stock shares in Q1 2024, an estimated $9.41M.
  • Eagle Asset Management first reported a position in Axonics, Inc. Common Stock in Q3 2020 and held it in 14 quarters.
  • Eagle Asset Management's Axonics, Inc. Common Stock position peaked at $25M in Q3 2022.
  • 235 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q1 2024.

Based on Eagle Asset Management's 13F filing for Q1 2024, filed 9 May 2024.